Fingerprint
Dive into the research topics of 'Clinical activity of enzalutamide versus docetaxel in men with castration-resistant prostate cancer progressing after abiraterone'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Clinical activity of enzalutamide versus docetaxel in men with castration-resistant prostate cancer progressing after abiraterone
Daniel L. Suzman, Brandon Luber, Michael T. Schweizer, Rosa Nadal, Emmanuel S. Antonarakis
Research output: Contribution to journal › Article › peer-review
72
Scopus
citations